FDA 510(k) Submission Services
Cruxi is an AI-assisted workspace for medical-device regulatory teams preparing submission materials. The official product page describes drafting, evidence organization, readiness checks and optional expert review. The existing catalog entry focuses on FDA 510(k) services; the platform also advertises other FDA and international submission workflows.
Organize the submission work
Cruxi describes AI-assisted device classification and predicate-device research. Those functions help assemble a starting analysis, but a team still needs to verify the proposed classification, source documents and comparison before relying on them. A generated pathway suggestion is not a regulator's determination.
The platform includes an eSTAR editor with drafting, review and export capabilities. Its evidence-planning tools let users upload, organize and manage supporting documents. That makes the workspace relevant when technical evidence, written sections and reviewers need to stay connected, rather than leaving the submission scattered across separate files.
The publisher also describes regulatory assessments and section-level content generation. Treat the generated text as material to reconcile against the actual device and its evidence, not an opportunity to fill missing studies with plausible prose.
Use checks alongside human review
Cruxi advertises pre-submission readiness checks, compliance recommendations, final QA reports and package export. These are software-assisted review steps, not proof that a submission meets every applicable requirement or will be accepted.
Optional regulatory-affairs expert review is available at critical checkpoints. A useful evaluation would establish who reviews the output, which documents they inspect and what responsibility remains with the submitting organization. Keep qualified regulatory professionals involved in decisions that affect a submission.
The homepage also has directories for consultants and service providers. Comparing a service provider is a separate decision from using the software's own drafting tools; the presence of a directory does not establish that every listed provider reviewed a generated package.
Check access and current terms
The site offers a free-start entry point without a card, but the captured page does not define a complete free usage allowance. Its displayed launch discount explicitly ended on May 21, 2026, so those promotional amounts should not be treated as current pricing.
Before uploading sensitive technical materials, confirm the current contract, data-handling terms and review arrangements. This overview describes the publisher's product workflow, not medical-device regulatory advice, an audited security assessment or a hands-on validation of submission accuracy.